Related Experiment Video
Updated: Feb 10, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Thoracoscopic stapler-and-loop technique for left atrial appendage closure in nonvalvular atrial fibrillation:
Toshiya Ohtsuka1, Takahiro Nonaka1, Motoyuki Hisagi1
1Department of Cardiovascular Surgery, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan.
Insights
Left atrial appendage (LAA) closure using a thoracoscopic stapler-and-loop technique is a safe and effective alternative to anticoagulation for preventing stroke in nonvalvular atrial fibrillation patients. This method achieved complete closure and acceptable mid-term prevention of cardiogenic thromboembolisms.
Area of Science:
- Cardiology
- Minimally Invasive Surgery
Background:
- Left atrial appendage (LAA) closure offers an alternative to oral anticoagulation for preventing cardiogenic thromboembolisms in patients with nonvalvular atrial fibrillation.
- The study focuses on evaluating a specific thoracoscopic technique for LAA closure.
Purpose of the Study:
- To retrospectively evaluate the safety, completeness, and mid-term prevention of a thoracoscopic stapler-and-loop technique for LAA closure.
- Assess the efficacy of LAA closure as an alternative to long-term anticoagulation.
Main Methods:
- Review of 201 patients operated on between October 2008 and February 2017 using endoscopic stapler and ligation loops.
- Primary endpoints included hospital death and major procedure-related complications; secondary endpoint was prevention of cardiogenic thromboembolisms.
- Brain MRI was used to investigate new thromboembolic spots one year post-surgery.
Main Results:
- A total of 201 patients (mean age 74 years, high CHA₂DS₂-VASc and HAS-BLED scores) underwent the procedure with a mean operation time of 28 minutes.
- All LAAs were completely closed, confirmed by intraoperative transesophageal echocardiography, with no hospital deaths or major complications.
- Mid-term follow-up (mean 48 months) in 198 patients showed 2 cases of cardiogenic thromboembolisms (0.25 events/100 patient-years); MRI revealed new spots in 3.9% of patients.
Conclusions:
- The thoracoscopic stapler-and-loop technique provides swift, safe, and complete LAA closure in patients with nonvalvular atrial fibrillation.
- This method offers acceptable mid-term prevention of thromboembolic events without the need for anticoagulation.
Background:
Left atrial appendage (LAA) closure can be an alternative to oral anticoagulation to prevent cardiogenic thromboembolisms in patients with nonvalvular atrial fibrillation.
Objective:
The purpose of this study was to retrospectively evaluate the safety, completeness, and mid-term prevention of our thoracoscopic stapler-and-loop technique for LAA closure.
Methods:
Patients operated on between October 2008 and February 2017 were reviewed. Endoscopic stapler and ligation loops were used. Patients received 1 month of anticoagulation before discontinuation. Hospital death and procedure-related major complications (thromboembolism, hemorrhagic events, phrenic palsy) were the primary composite endpoint for safety, and cardiogenic thromboembolisms were the endpoint for prevention. Brain magnetic resonance imaging investigated new thromboembolic spots 1 year after surgery.
Results:
There were 201 patients (118 men, 83 women) with a mean age of 74 years (range 68-94) years, mean CHA2DS2-VASc score (± SD) 4.1 ±1.4, and mean HAS-BLED score 2.9 ± 1.0. Mean operation time was 28 minutes. All LAAs were removed, and intraoperative transesophageal echocardiography confirmed completeness of the closure in each patient. No hospital deaths or major procedure-related complications occurred. Follow-up results for 198 patients (98%) over a mean period of 48 months (range 12-110) revealed that 2 patients developed cardiogenic thromboembolisms (0.25 event per 100 patient-years). Magnetic resonance imaging of 51 patients with a mean CHA2DS2-VASc score of 4.7 ± 1.6 revealed 1 new small spot in each of 2 patients (3.9%; 3.9 spots per 100 patient-years).
Conclusion:
Our thoracoscopic stapler-and-loop technique swiftly, safely, and completely closed LAAs in patients with nonvalvular atrial fibrillation and provided acceptable mid-term prevention without anticoagulation.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Surface Appendages of Archaea
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Predicting Reaction Outcomes

